Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data.

Eric Acquaviva 1, 2, * Stéphane Legleye 1, 3 Guy Auleley 4 Jean Deligne 5 Didier Carel 6 Bruno Falissard 1, 7
* Auteur correspondant
1 UMR_S 669 - Troubles du comportement alimentaire de l'adolescent
2 Service de psychopathologie de l'enfant et de l'adolescent
3 Observatoire Français des Drogues et toxicomanies
4 Caisse Nationale du RSI
5 Régime Social des Indépendants Nord - Pas de Calais
6 Urcam de Franche-Comté
7 Service de santé publique, évaluation et information médicale
Abstract : BACKGROUND: The aim of this work is to estimate the French frequencies of dispensed psychotropic prescriptions in children and adolescents. Prevalence estimations of dispensed prescriptions are compared to the frequencies of use of psychotropic reported by 17 year-old adolescents. METHODS: Prescription data is derived from national health insurance databases. Frequencies of dispensed prescriptions are extrapolated to estimate a range for the 2004 national rates. Self-report data is derived from the 2003 and 2005 ESCAPAD study, an epidemiological study based on a questionnaire focused on health and drug consumption. RESULTS: The prevalence estimation shows that the prevalence of prescription of a psychotropic medication to young persons between 3 and 18 years is about 2.2%.In 2005, the self-report study (ESCAPAD) shows that 14.9% of 17 year-old adolescents took medication for "nerves" or "to sleep" during the previous 12 months. The same study in 2003 also shows that 62.3% of adolescents aged 17 and 18 reporting psychotropic use, took the medication for anxiety and 56.8% to sleep. Only 49.7% of these medications are suggested by a doctor. CONCLUSION: This study underlines a similar range of prevalence of psychotropic prescriptions in France to that observed in other European countries. Nevertheless, the proportion of antipsychotics and benzodiazepines seems to be higher, whereas the proportion of methylphenidate is lower.Secondly, a disparity between the prevalence of dispensed prescriptions and the self-report of actual use of psychotropics has been highlighted by the ESCAPAD study which shows that these treatments are widely used as "self-medication".
Type de document :
Article dans une revue
BMC Psychiatry, BioMed Central, 2009, 9 (1), pp.72. 〈10.1186/1471-244X-9-72〉
Liste complète des métadonnées

Littérature citée [21 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00668480
Contributeur : Ed. Bmc <>
Soumis le : jeudi 9 février 2012 - 17:24:17
Dernière modification le : mardi 5 décembre 2017 - 16:44:06
Document(s) archivé(s) le : mercredi 14 décembre 2016 - 04:45:53

Fichiers

1471-244X-9-72.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UNIV-PARIS5 | USPC

Citation

Eric Acquaviva, Stéphane Legleye, Guy Auleley, Jean Deligne, Didier Carel, et al.. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data.. BMC Psychiatry, BioMed Central, 2009, 9 (1), pp.72. 〈10.1186/1471-244X-9-72〉. 〈inserm-00668480〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

381

Téléchargements de fichiers

238

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD